Vitamin D Analogues in Colon Cancer Prevention and Care

被引:3
作者
Beildeck, Marcy E.
Byers, Stephen W.
机构
关键词
D O I
10.1007/s11888-009-0026-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Evidence for a cancer preventive role for vitamin D has been accumulating since the early 1980s, most signifi cantly in blood, breast, and, most notably, colon cancers. Although vitamin D and its metabolites modulate proliferation, angiogenesis, differentiation, and apoptosis, their major function is to maintain calcium homeostasis. Thus, treatment with vitamin D may cause an imbalance of calcium, manifesting in clinical disorders such as hypercalcemia and hypercalciuria. To circumvent these side effects, two branches of research have evolved. The first aims to understand the molecular targets that contribute to the anticancer properties of vitamin D; the second aims to develop vitamin D analogues that retain anticancer properties but have diminished hypercalcemic properties. The purpose of this article is to review the literature regarding failures and successes of vitamin D analogues in colon cancer research.
引用
收藏
页码:185 / 196
页数:12
相关论文
共 62 条
[1]
Vitamin D-3 analogue (EB 1089) inhibits in vitro cellular proliferation of human colon cancer cells [J].
Akhter, J ;
Goerdel, M ;
Morris, DL .
BRITISH JOURNAL OF SURGERY, 1996, 83 (02) :229-230
[2]
Vitamin D-3 analog, EB1089, inhibits growth of subcutaneous xenografts of the human colon cancer cell line, LoVo, in a nude mouse model [J].
Akhter, J ;
Chen, XH ;
Bowrey, P ;
Bolton, EJ ;
Morris, DL .
DISEASES OF THE COLON & RECTUM, 1997, 40 (03) :317-321
[3]
Selective inhibition of cyclooxygenase-2 (COX-2) by 1α,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog [J].
Aparna, Rachamallu ;
Subhashini, Jagu ;
Roy, Karnati R. ;
Reddy, G. Satyanarayana ;
Robinson, Matthew ;
Uskokovic, Milan R. ;
Reddy, Gorla Venkateswara ;
Reddanna, Pallu .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2008, 104 (05) :1832-1842
[4]
Inter-species differences in sensitivity to the calcemic activity of the novel 1,25-dihydroxyvitamin D3 analog BXL746 [J].
Baroni, Enrico ;
Camisa, Barbara ;
D'Ambrosio, Daniele .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2008, 52 (03) :332-341
[5]
Beer TM, 2001, CANCER-AM CANCER SOC, V91, P2431, DOI 10.1002/1097-0142(20010615)91:12<2431::AID-CNCR1278>3.0.CO
[6]
2-3
[7]
Bischof MG, 1995, J PHARMACOL EXP THER, V275, P1254
[8]
Molecular basis of the selective activity of vitamin D analogues [J].
Carlberg, C .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 88 (02) :274-281
[9]
Cross HS, 1996, ANTICANCER RES, V16, P2333
[10]
CROSS HS, 1993, N-S ARCH PHARMACOL, V347, P105